14.1
GT Biopharma, Inc.
Metrics score locked — part of Premium
FY23
FY24
FY25
FY25
FY25
FY23 – FY25
Assets
(positive)
Change from FY23 to FY25
millions USD
FY23:
FY24:
4.23
FY25:
–
FY25:
–
FY25:
8.11
(positive)
Change from FY23 to FY25
millions USD
FY23:
0.05
FY24:
0
FY25:
–
FY25:
–
FY25:
0
Total assets
Change from FY23 to FY25
millions USD
FY23:
14.1
FY24:
4.23
FY25:
7.12
FY25:
4.32
FY25:
8.11
Liabilities & Equity
(negative)
Change from FY23 to FY25
millions USD
FY23:
6.63
FY24:
5.90
FY25:
–
FY25:
–
FY25:
2.32
(negative)
millions USD
FY23:
0
FY24:
0
FY25:
–
FY25:
–
FY25:
0
(positive)
Change from FY23 to FY25
millions USD
FY23:
7.48
FY24:
−1.67
FY25:
−25.9
FY25:
3.00
FY25:
5.79
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY23:
14.1
FY24:
4.23
FY25:
–
FY25:
4.32
FY25:
8.11
All amounts in millions USD